Therapeutic Asset Ratings
2,273 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sargramostim
Metastatic Malignant Neoplasm
Mayo Clinic
P2
BB
(64)
Sargramostim
Metastatic Melanoma
Mayo Clinic
P2
BB
(64)
Sargramostim
Triple-Negative Breast Carcinoma
University of Washington
P2
BB
(64)
Tirzepatide
Non-alcoholic Steatohepatitis
Dr Adnan Agha
P2
BB
(64)
FILGRASTIM
Minimal Residual Disease
Masonic Cancer Center, University of Minnesota
P2/3
BB
(64)
FILGRASTIM
Thalassemia
St. Jude Children's Research Hospital
P2/3
BB
(64)
FILGRASTIM
T Lymphoblastic Lymphoma
Children's Oncology Group
P2/3
BB
(64)
Semaglutide
Heart Failure
University Medical Centre Ljubljana
P2/3
BB
(64)
CYCLOSPORIN A
Nephrotic Syndrome
Alexandria University
P4
B
(63)
Ganirelix
Polycystic Ovary Syndrome
University Hospital, Lille
P4
B
(63)
Genotropin
Obesity Disorder
Columbia University
P4
B
(63)
INSULIN GLARGINE (SANOFI)
Hyperglycemia
The First Affiliated Hospital of Xiamen University
P4
B
(63)
LEUPROLIDE
Breast Neoplasm
Eli Lilly and Company
P4
B
(63)
LEUPROLIDE
HER2-negative Breast Cancer
Olema Pharmaceuticals, Inc.
P4
B
(63)
Palifermin
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P4
B
(63)
ABATACEPT RECOMBINANT
Acute Biphenotypic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P3
B
(63)
ASPARAGINASE
T-Cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
B
(63)
Calaspargase Pegol
Mixed Phenotype Acute Leukemia
St. Jude Children's Research Hospital
P3
B
(63)
Calaspargase Pegol
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
B
(63)
DOTATOC
Digestive System Neuroendocrine Neoplasm
Jiangsu HengRui Medicine Co., Ltd.
P3
B
(63)
Endostar
Colorectal Neoplasm
First Affiliated Hospital Xi'an Jiaotong University
P3
B
(63)
FILGRASTIM
Anaplastic Large Cell Lymphoma, ALK-Negative
Eastern Cooperative Oncology Group
P3
B
(63)
FILGRASTIM
Angioimmunoblastic T-Cell Lymphoma
City of Hope Medical Center
P3
B
(63)
FILGRASTIM
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P3
B
(63)
FILGRASTIM
Plasma Cell Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Showing 476 to 500 of 2,273 assets
Previous
Page 20 of 91
Next